Outlook Therapeutics, Inc. (OTLK) Financials
OTLK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 21.7 million | 46.0 million |
2023-09-30 | 32.3 million | 46.7 million |
2023-06-30 | 44.4 million | 50.0 million |
2023-03-31 | 54.0 million | 43.5 million |
OTLK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -13.0 million | 1.3 million |
2023-09-30 | -12.7 million | 1.4 million |
2023-06-30 | -13.2 million | 1.4 million |
2023-03-31 | -8.1 million | 1.4 million |
OTLK Net Income
No data available :(
OTLK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 10.4 million | - | 1084 |
2023-09-30 | 23.4 million | - | 4267 |
2023-06-30 | 33.7 million | - | 7349 |
2023-03-31 | 43.6 million | - | 14261 |
OTLK Shares Outstanding
OTLK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 4.5 million | 5.8 million | - |
2023-09-30 | - | 4.9 million | 7.5 million | - |
2023-06-30 | - | 11.1 million | 7.0 million | - |
2023-03-31 | - | 545000 | 6.3 million | - |
OTLK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 28195 |
2023-09-30 | - | 11217 |
2023-06-30 | - | 11192 |
2023-03-31 | - | 11001 |
OTLK
Price: $8.60
52 week price:
Earnings Per Share: -4.00 USD
P/E Ratio: -1.87
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 308347
Market Capitalization: 200.4 million